J&J Drug Reduces Prostate Cancer Spread and Death Risk

A Johnson & Johnson drug has shown effectiveness in reducing the risk of prostate cancer spread and death. The company is also seeking expanded use for the drug following a positive study on head and neck cancer.

31 May, 14:34 — 31 May, 14:34

Post Share

Sources

Showing 1 of 2 sources

straits-timesMostly Factual75d ago

J&J prostate cancer drug reduces risk of cancer spread, death - The Straits Times

J&J prostate cancer drug reduces risk of cancer spread, death The Straits Times

Read full article →

Coverage Timeline

First report: seeking-alpha · 31 May, 14:31|Full coverage: 2 · 3m|Window: 3m

Left-leaningCenterRight-leaning

seeking-alpha31 May, 14:31First to report

J&J seeks expanded use for drug after positive head and neck cancer study

straits-times31 May, 14:34Latest update

PERSPECTA

PERSPECTA

J&J Drug Reduces Prostate Cancer Spread and Death Risk

Sources

J&J prostate cancer drug reduces risk of cancer spread, death - The Straits Times

Coverage Timeline

J&J seeks expanded use for drug after positive head and neck cancer study

J&J prostate cancer drug reduces risk of cancer spread, death - The Straits Times

Related Stories

Jeff Bezos Consortium Acquires 30% Stake in Liverpool FC

Uber Plans to Deploy 2,000 Robotaxis in Europe

Belgian Students Discover €9 Million Gold Stash in House

Former Moldovan MP Denies Bribery Allegations in Metal Waste Market

PERSPECTA